251 related articles for article (PubMed ID: 9283213)
61. Evaluating prethrombotic state in lung cancer using molecular markers.
Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
[TBL] [Abstract][Full Text] [Related]
62. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
Vaziri ND; Gonzales EC; Wang J; Said S
Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
[TBL] [Abstract][Full Text] [Related]
63. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Yamada S; Asakura H
Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
[TBL] [Abstract][Full Text] [Related]
64. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis.
Takagi M; Wada H; Mukai K; Minamikawa K; Wakita Y; Deguchi K; Junji N; Hayashi T; Suzuki K; Shiku H
Clin Appl Thromb Hemost; 1999 Apr; 5(2):113-6. PubMed ID: 10725991
[TBL] [Abstract][Full Text] [Related]
65. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
Huang K; Mo Q; Liao C; Feng S; Liu G; Jiang D; Lei P
Clin Exp Med; 2024 May; 24(1):107. PubMed ID: 38776019
[TBL] [Abstract][Full Text] [Related]
66. Change of lipoprotein (a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy.
Nagai T
J Atheroscler Thromb; 1994; 1(1):37-40. PubMed ID: 9222867
[TBL] [Abstract][Full Text] [Related]
67. The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy.
Terao T; Maki M; Ikenoue T; Gotoh K; Murata M; Iwasaki H; Shibata J; Nakabayashi M; Muraoka M; Takeda Y
Gynecol Obstet Invest; 1991; 31(2):74-85. PubMed ID: 1828053
[TBL] [Abstract][Full Text] [Related]
68. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
[TBL] [Abstract][Full Text] [Related]
69. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
Fujiwara Y; Tagami S; Kawakami Y
J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
[TBL] [Abstract][Full Text] [Related]
70. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
[TBL] [Abstract][Full Text] [Related]
71. Alterations in coagulation and fibrinolysis during sepsis.
Kidokoro A; Iba T; Fukunaga M; Yagi Y
Shock; 1996 Mar; 5(3):223-8. PubMed ID: 8696988
[TBL] [Abstract][Full Text] [Related]
72. Changes in peritoneal coagulation and fibrinolysis after discontinuation of chronic peritoneal dialysis.
Homma S; Masunaga Y; Kurosu M; Inoue M; Sakurai T; Asano Y
Perit Dial Int; 2002; 22(2):178-83. PubMed ID: 11990401
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of blood coagulation-fibrinolysis system in patients receiving chronic hemodialysis.
Ishii Y; Yano S; Kanai H; Maezawa A; Tsuchida A; Wakamatsu R; Naruse T
Nephron; 1996; 73(3):407-12. PubMed ID: 8832598
[TBL] [Abstract][Full Text] [Related]
74. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
[TBL] [Abstract][Full Text] [Related]
75. Activation of blood coagulation and fibrinolysis in vibration syndrome.
Shunto R; Shirakami A; Ohara A; Toibana N; Saito S
Int Arch Occup Environ Health; 1991; 63(4):293-6. PubMed ID: 1720765
[TBL] [Abstract][Full Text] [Related]
76. Performance evaluation of thrombomodulin, thrombin-antithrombin complex, plasmin-α2-antiplasmin complex, and t-PA: PAI-1 complex.
Chen Q; Shou W; Wu W; Wang G; Cui W
J Clin Lab Anal; 2019 Jul; 33(6):e22913. PubMed ID: 31090232
[TBL] [Abstract][Full Text] [Related]
77. Hemostasis in newborns of smoking and nonsmoking mothers.
Mercelina-Roumans PE; Ubachs JM; van Wersch JW
Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
[TBL] [Abstract][Full Text] [Related]
78. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism.
Tohgi H; Kawashima M; Tamura K; Suzuki H
Stroke; 1990 Dec; 21(12):1663-7. PubMed ID: 2148232
[TBL] [Abstract][Full Text] [Related]
79. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia.
Yamanaka A; Kimura F; Yoshida T; Kita N; Takahashi K; Kushima R; Murakmai T
Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():99-103. PubMed ID: 27543913
[TBL] [Abstract][Full Text] [Related]
80. [New clinical tests in diagnosis of hematologic diseases].
Nakahara K
Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):529-33. PubMed ID: 8340662
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
